维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="MASON JO"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema 显示文摘	Mason JO 3rd Albert MA Jr Vail R	2006	Retina2006，26，3：	1
2	Morphine and fentanyl hypnotic interactions with thiopental in relation to movement response to noxious stimulation显示文摘	Kissin I Mason JO Bradley EL	1986	Anesth Analg1986，65，：	1
3	Intravitreal concentration and clearance of triamcinolonc acetonide in nonvitrctomized human eyes显示文摘	Mason JO Somaiva MP Singh RJ	2004	Retina2004，24，6：	1
4	The influence of alloxan-indu- ced diabetes on M0 ller cell contraction-promoting activities in vitreous显示文摘	King JL Mason JO Cartuer SC	2011	Invest Ophthalmol Vis Sci2011，52，10：	1
5	Incidence of acute onset endophthalmitis following intravitreal bevacizumab(Avastin) injection显示文摘	Mason JO 3rd White MF Feist RM	2008	Retina2008，28，：	1
6	Intravitreal bevacizumab (Avastin)prevention of panretinal photocoagulation-indueed com- plications in patients with severe proliferative diabetic retinopa- thy显示文摘	Mason JO Yunker J J Vail R	2008	Retina2008，28，9：	1
7	Intravitreal injection of bevaci- zumab(Avastin)as adjunctive treatment of proliferative diabetic retinopathy显示文摘	Mason JO Nixon PA White MF	2006	Am J Ophthalmol2006，142，4：	1
8	Adenomatous polyposis coli is required for early events in the normal growth and differentiation of the developing cerebral cortex 显示文摘	Ivaniutsin U Chen Y Mason JO	2009	NeuralDev2009，4，1：	1
9	Intravitreal bavacizumab(Avastin)for refractory pseudopakic cystoid macular edema显示文摘	Mason JO 3rd Albert MA Jr Vail R		0，，03：	1
10	Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy 显示文摘	Mason JO 3rd Colagross CT Haleman T Fuller JJ White MF Feist RM	2005	Am J Ophthalmol2005，140，2：	1
11	Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma 显示文摘	Mason JO Fischer DH	2003	Ophthalmology2003，110，6：	1
12	Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes 显示文摘	Mason JO Somaiya MD Singh RJ	2004	Retina2004，24，6：	1
13	Regression of neovascular iris vessels by intravitreal injection of bevacizumab 显示文摘	Mason JO 3rd Albert MA Jr Mays A Vail R	2006	Retina2006，26，7：	1
14	Fibrocontractive muller cell phenotypes in proliferative diabetic retinopathy显示文摘	Guidry C King JL Mason JO 3rd	2009	Invest Ophthalmol Vis Sci2009，50，4：	1
15	Regression of neovasculariris vessels by intravitreal iryection of bevacizumab显示文摘	Mason JO Albert MA Mays A Vail R	2006	Retina2006，26，7：	1
16	Visual outcom and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy 显示文摘	Mason JO 3rd Colagross CT Haleman T	2005	Am J Ophthalmo12005，140，2：	1
17	Pax3 regulates Wnt1 ex?pression via a conserved binding site in the 5' proximal pro?moter显示文摘	Fenby BT Fotaki V Mason JO	2008	Biochim Biophys Acta2008，1779，：	1
18	Treatment of trigeminal neuralgia and other facial pains by retrogasseran injection of glycerol显示文摘	Sweet WH Polettc CE Mason Jo	1981	Neurosurgery1981，9，：	1
19	Expression profiles of Wnt genes during neural differentiation of mouse embryonic stem cells 显示文摘	Nordin N Li M Mason JO	2008	Cloning Stem Cells2008，10，1：	1
20	Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema 显示文摘	Mason JO Ill Albert MA Jr Vail R	2006	Retina2006，26，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示